Status:
COMPLETED
dHealth Solution for Improving Parent Adherence to Behavioral Treatment for ADHD
Lead Sponsor:
University of California, San Francisco
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
6-85 years
Phase:
NA
Brief Summary
This study aims to develop, refine and preliminarily test a novel and scalable digital health solution designed to address parent adherence barriers in daily life contexts and increase parent's sustai...
Detailed Description
The study includes the following 3 phases: 1. Discovery phase: During the Discovery phase, we will conduct 1-hour focus groups at school sites with parents (N=8) and school mental health providers (N...
Eligibility Criteria
Inclusion
- Child aged 6-11 (grades 1-5)
- Identification by school mental health professionals as experiencing challenges with inattention and/or hyperactivity/impulsivity
- Attending a participating SFUSD elementary school full time in a mainstream classroom
- Living with a caretaker who is available to participate in treatment
- Absence of significant visual/hearing impairment, severe language delay, psychosis, pervasive developmental disorder, or global intellectual impairment per school records
- Significant ADHD symptoms as evidenced by having (i) six or more symptoms of inattention and/or hyperactivity/impulsivity rated as occurring "often" or "very often" by parents, (ii) at least one area of functioning rated as -≥ 3 on the Impairment Rating Scale by parent
Exclusion
- No presence of conditions that are incompatible with this study's treatment including: severe visual or hearing impairment, severe language delay or intellectual impairment, psychosis, pervasive developmental disorder,
- Child is in an all-day special education classroom (children in these classrooms are frequently receiving intensive behavior modification programs such that the intervention would be expected to require modification for use in these settings)
- Children planning to change (start or stop) psychotropic medication Note: Children taking medication will be required to meet all entry criteria, including impairment criteria, thus indicating a need for the intervention. Children taking medication for attention or behavior are eligible as long as their medication regimens are stable.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 12 2024
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT04025814
Start Date
August 1 2020
End Date
November 12 2024
Last Update
July 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HALP Clinic, Children's Center at Langley Porter, UCSF
San Francisco, California, United States, 94143